Contingent Value Rights Substack

Share this post

User's avatar
Contingent Value Rights Substack
Sigilon Therapeutics acquired by Eli Lilly (LLY) for $14.92/sh in cash plus contingent payments up to $111.64/sh

Sigilon Therapeutics acquired by Eli Lilly…

Contingent Value Rights
Aug 15, 2023

Share this post

User's avatar
Contingent Value Rights Substack
Sigilon Therapeutics acquired by Eli Lilly (LLY) for $14.92/sh in cash plus contingent payments up to $111.64/sh

Last trade before it stopped trading $22.47 / Final CVR expires December 31, 2031.

Read →
Comments
User's avatar
© 2025 Contingent Value Rights
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share